Autopsy report · NCT01575028
Transversus Abdominis Plane (TAP) Versus Local Anesthetic for Lap Appendectomies
Cause of deathSlow enrollment
“The study was allowed to expire due to changes in standard care for the patient population within the NCH institution.”
Life of this trial
- Registered 6 months before it started.
- Ran for about 1 year 9 months before it stopped.
- 3 participants enrolled.
- Results were posted on the registry 11 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2
- Sponsor
- Nationwide Children's Hospital
- Sponsor type
- University, hospital or other
- Conditions
- Appendicitis
- Interventions
- Ropivacaine; Bupivacaine
- Participants
- 3
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Antiepileptic Drugs and Vascular Risk Markers
“study no longer consistent with current clinical practice” - Developmental Correlates and Hormone Therapy Effects in Gender Dysphoria
“the patients are now followed in another hospital. The study is discontinued” - A Comparison of the Post-C/S Analgesic Effects of Neuraxial Duramorph vs Bilateral TAP Block With Liposomal Bupivacaine
“Standard of Care changed due to COVID-19 and thus had to stop the study.” - Double-dose Rabeprazole Accelerates and Sustains the Control of Symptoms in Patients With NERD
“patients could not be recuited within study duration” - Efficacy and Safety of Clevudine Compared With Adefovir in Patients With Chronic Hepatitis Due to Hepatitis B Virus
“The study was terminated in the interest of patient safety.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.